Stroke prevention: Learning from the master (and <i>COMMANDER</i>).

Santulli, Gaetano · Sci Transl Med · 2018

editorial · Level V

Where this comes from

Abstract

Adding rivaroxaban to standard therapy in patients with heart failure and no atrial fibrillation did not show any beneficial effect on death risk.

Medical subject headings